Sanofi Takes Over News Stories for Pharma

In the pharmaceutical landscape, Sanofi emerged as a central figure in April 2023 news stories, acting as an innovator and educator.

This report highlights Sanofi's involvement in the development of treatments for Respiratory Syncytial Virus (RSV) alongside AstraZeneca. Their active role in combating the pharmaceutical counterfeiting problem through collaborations with the Intellectual Property Office of the Philippines also caught media attention. Additionally, Sanofi advocates for professional education via its innovative PharmAcademy program aimed at enhancing Filipino pharmacists' knowledge and skills.

Media monitoring helps pharmaceutical companies connect with their consumers. Read more about this report.